Affymetrix Says Adoption of Lower-Priced Products Contributed to 4 Percent Fall in Q4 Revenue | GenomeWeb

This story was first posted on Feb. 4.

By Justin Petrone

A growing number of researchers switching to lower-priced arrays led Affymetrix to post a 4 percent decline in fourth-quarter revenue.

Product revenues for the three months ended Dec. 31, 2010, declined 12 percent from a year ago. The results mirrored a 5 percent decline in full-year 2010 product revenues.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.